CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Open-market buy Director bought 65,022 shares at an average $4.64 ($301,688)
- 4 Open-market buy 10% owner bought 176,870 shares at an average $4.52 ($799,907)
- 4 Open-market buy Director bought 111,848 shares at $4.47 ($500,419)
- 4 Open-market sale SVP & Chief Compliance Officer sold 394 shares at $2.83 ($1,115)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 1,813 shares (option exercise)
- 4 Exercise or conversion Director acquired 386 shares (option exercise)
- 4 Exercise or conversion Director acquired 965 shares (option exercise)
- 4 Open-market buy Director bought 292,126 shares at an average $3.38 ($987,185)
- 4 Open-market buy Director bought 455,725 shares at an average $2.94 ($1,338,164)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4/A Open-market sale SVP & Chief Compliance Officer sold 131 shares at an average $7.69 ($1,007)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
Page 7 of 13 · 251 filings